Section one: Contracting authority
one.1) Name and addresses
NHS England
Quarry House
Leeds
LS2 7UE
Country
United Kingdom
NUTS code
UKE - Yorkshire and the Humber
Internet address(es)
Main address
Buyer's address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
Tenders or requests to participate must be submitted to the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
UK Domestic Plasma Fractionation Service
Reference number
C51842
two.1.2) Main CPV code
- 33651520 - Immunoglobulins
two.1.3) Type of contract
Supplies
two.1.4) Short description
NHS England and NHS Improvement (NHSEI) is undertaking a competitive dialogue process to select a single organisation to provide a toll fractionation service using UK Plasma. Please see below/ procurement documents for full details.
two.1.5) Estimated total value
Value excluding VAT: £600,000,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.2) Additional CPV code(s)
- 33651520 - Immunoglobulins
- 33651520 - Immunoglobulins
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
NHS England and NHS Improvement (NHSE&I) in conjunction with NHS Blood and Transplant (NHSBT) issued Prior Information Notices (PIN) in August 2021 and January 2022, seeking to gather information and feedback from the plasma fractionation market, as recognised experts, to help inform the strategy to contract for fractionation services using UK plasma.
Having reflected upon the feedback received, NHSE&I is now commencing a Competitive Dialogue process, to select a single organisation to provide a toll fractionation service using UK plasma.
The UK recognises that medicinal products derived from UK plasma have not been manufactured for more than 20 years. As such there is a much to learn and/or relearn. This procurement, and the wider project its supports, are therefore seen as the UK’s initial step (or pilot project) to achieve partial self-sufficiency for plasma derived medicinal products for the exclusive use of NHS patients in the UK.
As such, this procurement is not expected to be a one off exercise. Rather the learning from this project is expected to inform future procurements and how the UK works with selected fractionators to achieve its long term ambitions for self-sufficiency.
As regards Northern Ireland, Scotland and Wales, the respective Blood Services (represented by their hosting bodies where applicable) for each of the regions have expressed interest in this procurement. Therefore the Blood Services for each region (including their hosting bodies where applicable), the Devolved Administration for each region and the NHS providers in each region (as potential buyers of products derived from fractionation) are included by NHSE&I as Participating Authorities ("PAs") within this Contract Notice, as further defined in the tender documents.
This provides an option for each of the above bodies to be a party to the contractual arrangements that will result from this procurement (by entering into essentially identical but separate contracts, under the law and jurisdiction of the relevant region in each case), but does not bind them to do so. Further details of the decision and implementation processes for the PAs in Northern Ireland, Scotland and Wales will be provided during the next stage of this procurement (Invitation to Participate in Dialogue
The Authority and PA’s reserve the right to amend any plasma volumes stated within the procurement documents.
Interested organisations can register their interest and access the procurement documents for full details here https://health-family.force.com/s/Welcome
Once registered, you will be invited to sign a tripartite non-disclosure agreement (NDA). If you have previously signed an NDA as part of the 2 PIN notices issued for this tender, the NDA continues to apply during the tender period and until a contract has been entered into.
The deadline for completion of the Selection Questionnaire within Atamis is 12th May 2022 at 13:00hrs
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £600,000,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months
84
This contract is subject to renewal
No
two.2.9) Information about the limits on the number of candidates to be invited
Envisaged minimum number: 3
Maximum number: 5
Objective criteria for choosing the limited number of candidates:
Please see procurement documents for full details
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
two.2.14) Additional information
Please see procurement documents for full details
Section three. Legal, economic, financial and technical information
three.1) Conditions for participation
three.1.1) Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions
Please see procurement documents for full details
three.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
three.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
three.2) Conditions related to the contract
three.2.2) Contract performance conditions
Please see procurement documents for full details
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Competitive dialogue
four.1.4) Information about reduction of the number of solutions or tenders during negotiation or dialogue
Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.1) Previous publication concerning this procedure
Notice number: 2022/S 000-001284
four.2.2) Time limit for receipt of tenders or requests to participate
Date
12 May 2022
Local time
1:00pm
four.2.3) Estimated date of dispatch of invitations to tender or to participate to selected candidates
11 April 2022
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Tender must be valid until: 1 November 2023
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: No
six.2) Information about electronic workflows
Electronic ordering will be used
six.4) Procedures for review
six.4.1) Review body
NHS England
Skipton House, 80 London Road
London
SE1 6LH
Country
United Kingdom